Does concurrent paclitaxel and radiation therapy improve outcomes in patients with cutaneous angiosarcoma?
Concurrent paclitaxel and radiation therapy shows promising outcomes for cutaneous angiosarcoma, prompting an ongoing phase 2 trial.
The use of concurrent paclitaxel CRT demonstrates promising outcomes. Given these results, we are currently evaluating the safety and efficacy of this regimen in prospective, phase 2 trial (NCT03921008).
Roy et al. (Thu,) studied this question.